Corneal endothelial deposits in patients with HIV infection or AIDS: Epidemiologic evidence of the contribution of rifabutin

Canadian Journal of Ophthalmology

Volumn 34, Issue 4, 1999, Pages 204-209

  Holland, Simon P ^a   Chang, Charmaine W ^a   Vagh, Mustali ^a   Courtright, Paul ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Acquired immunodeficiency syndrome; AIDS; Cytomegalovirus retinitis; HIV; Human immunodeficiency virus

Indexed keywords

RIFABUTIN;

ADULT; ARTICLE; CLINICAL FEATURE; CORNEA ENDOTHELIUM; CORNEA INJURY; DIFFERENTIAL DIAGNOSIS; DRUG DETERMINATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; RETINITIS;

EID: 0032718513     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Nightingale SD, Cameron DW, Gordin FM, Sullam PM, Cohn DL, Chaisson RE, et al. Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS. N Engl J Med 1993;139: 828-33.
2. Chin DP, Hopewell PC. How to treat bacteraemic Mycobacterium avium complex disease. Lancet 1995;346: 920-1.
3. Jacobs DS, Pillero PJ, Kuperwaser MG, Smith JA, Harris SD, Flanigan TP, et al. Acute uveitis associated with rifabutin use in patients with human immunodeficiency virus infection. Am J Ophthalmol 1994;118:716-22.
4. Havlir D, Torriani F, Dube M. Uveitis associated with rifabutin prophylaxis. Ann Intern Med 1994;121:510-2.
5. Brogden RN, Fitton A. Rifabutin, a review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1994;47:983-1009.
6. Griffith DE, Brown BA, Girard WM, Wallace RJ Jr. Adverse events associated with high-dose rifabutin in macrolide-containing regimens for the treatment of Mycobacterium avium complex lung disease. Clin Infect Dis 1995;21:594-8.
7. Fuller JD, Stanfield LE, Craven DE. Rifabutin prophylaxis and uveitis [letter]. N Engl J Med 1994;330:1315-6.
8. Saran BR, Maguire AM, Nichols C, Frank I, Hertle RW, Brucker AJ, et al. Hypopyon uveitis in patients with acquired immunodeficiency syndrome treated for systemic Mycobacterium avium complex infection with rifabutin. Arch Ophthalmol 1994;112:1159-65.
9. Uveitis associated with rifabutin therapy. MMWR 1994;43: 658.
10. Karbassi M, Nikou S. Acute uveitis in patients with acquired immunodeficiency syndrome receiving prophylactic rifabutin. Arch Ophthalmol 1995;113:699-701.
11. Whitecup SM. Ocular manifestations of AIDS. JAMA 1996;275:142-4.
12. Walter KA, Coulter VI, Palay PA, Taravella MJ, Grossniklaus HE, Edelhauser HF. Corneal endothelial deposits in patients with cytomegalovirus retinitis. Am J Ophthalmol 1996;121:391-6.
13. Mitchell SM, Barton K, Lightman S. Corneal endothelial changes in cytomegalovirus retinitis. Eye 1994;8:41-3.
14. Severin M, Cartmann C. Endothelial alterations in AIDS with cytomegalovirus infection. Ophthalmologica 1988; 196:7-10.
15. Horsburgh CR. Advances in the prevention and treatment of Mycobacterium avium disease. N Engl J Med 1996;335: 428-9.
16. Pierce M, Crampton S, Henry D, Heifets L, LaMarca A, Montecalvo M, et al. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome. N Engl J Med 1996;335:384-91.
17. Havlir DV, Dube MP, Sattler FR, Forthal DN, Kemper CA, Dunne MW, et al. Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. N Engl J Med 1996;335: 392-8.